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Abstract In order to establish a subtractive procedure that 
makes it possible to enrich selectively phage displayed antibodies 
directed against proteins constituting a difference between two 
populations of cells, a competitive selection strategy utilising two 
solid phases was developed and tested. Antibodies recognising a 
defined difference between two otherwise identical protein 
mixtures were isolated and their specificity confirmed. To test 
further the efficacy of selection inhibition during the competitive 
selections, selections towards a total cell extract were performed 
with and without competition from the same extract. An analysis 
of the resulting phage antibodies confirmed the subtractive 
nature of the system described. 
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1. Introduction 
Since 1985 when George Smith introduced the idea of dis- 
playing peptides in fusion with the minor coat protein, pill, of 
filamentous phage [1], phage display technology has found 
many applications in the study of molecular ecognition [2]. 
In recent years, libraries of antibody fragments have been 
cloned for display on the surface of filamentous phage, and 
phage antibodies have been selected against a variety of anti- 
gens, thus providing an important alternative to the hybrido- 
ma technology [3-5]. Phage display antibody libraries are con- 
structed from V-gene repertoires, which can be obtained from 
either immunised [6,7] or non-immunised (naive) [8,9] sources. 
The advantage of large naive libraries over immunised is that 
phage antibodies against virtually any antigen can be identi- 
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fled from one single library, by using selection and amplifica- 
tion procedures to mimic the immune system [10-14]. 
Because antibodies bind specifically to their target mole- 
cules, they have wide applications as molecular probes for 
identifying a particular antigen in cells, tissues or biological 
fluids. Much effort has been put into identifying antibodies 
against specific biomarkers, since such reagents can be useful 
in studying the biological processes that define a given cell, or 
in targeting diagnostic and therapeutic agents [15-17]. Phage 
display libraries are likely to prove useful tools, as they offer 
the potential of selecting against many different ligands at the 
same time, thereby obtaining a complementary image of the 
molecules expressed. Accordingly, antibodies and peptides 
that are cell-selective have been isolated by panning phage 
display libraries against intact cells [18,19]. 
In the search for biomarkers, however, it is essential to use 
a subtractive strategy to provide information about differ- 
ences, i.e. cell-specific markers, rather than similarities. 
Thus, by combining flow cytometry with selection from a 
naive phage display antibody library, it has been possible to 
separate sub-populations of cells, and to isolate sub-type-spe- 
cific phage antibodies [20]. Other approaches, to enrich selec- 
tively for binders to new epitopes, have taken advantage of 
competitive lution with a known monoclonal antibody [21] 
or masking of an epitope with a known monoclonal antibody 
[22]. These techniques, however, rely on pre-existing monoclo- 
nal antibodies that bind specifically to the target molecules or 
target cells of interest, so a more general approach would be 
desirable. Hence, using a library constructed from peripheral 
blood lymphocytes of auto-immunised melanoma patients, 
phage antibodies that react with melanoma cells but not 
with melanocytes were isolated by adsorbing the panned 
phage against normal melanocytes, and cloning the unad- 
sorbed phage [23]. Other investigators have used pre-adsorp- 
tion of the naive library before panning to obtain a similar 
effect [18]. Finally, a very simple approach towards selection 
inhibition has been to perform selections in the presence of 
soluble competitor [13,24]. 
The specific aim of this study was to develop a simple 
procedure, by which phage antibodies can be raised against 
cytosolic ell population-specific proteins. A competitive bio- 
panning procedure was developed and tested on two model 
systems, using a naive phagemid library of single-chain Fv 
antibody fragments (scFv) expressed on phage [11]. The re- 
sults confirm that preferential selection can be obtained from 
naive phage display libraries, and suggest that the subtractive 
strategy presented is valuable in attempts to identify antibod- 
ies against known or unknown antigens in a given population 
of cells. 
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2. Mater ia l s  and methods  
2.1. Library and bacteria 
A naive phagemid library of approximately 108 clones of scFv ex- 
pressed on phage [11] was kindly provided by Dr Greg Winter, MRC, 
Cambridge, UK. TG-1 (K12, A(lac-pro), supE, thi, hsdD5/F'traD36, 
proA+B +, lacl q, lacZAM15) and HB2151 (K12, ara, (lac-pro), thi/ 
F'proA+B +, lacqZAM15) were used to produce phage displayed 
scFv and soluble scFv, respectively. 
2.2. Proteins 
c~-Lactalbumin from bovine milk (L5385), [3-1actoglobulin from bo- 
vine milk (L2506), soybean trypsin inhibitor (T9003), bovine catalase 
(CI00), and bovine serum albumin (A4503) were all obtained from 
Sigma Chemical Co. Lactate dehydrogenase from rabbit muscle 
(127230) and creatine kinase from rabbit muscle (126969) were from 
Boehringer Mannheim GmbH. 
2.3. Cell culture and cytosolic cell extracts 
The melanoma cell line (FM55p) was a kind gift from Dr Jesper 
Zeuthen, Danish Cancer Society, Copenhagen, Denmark [25]. The 
cells were grown in RPMI 1640 medium (Dulbecco, Life Technolo- 
gies) supplemented with 10% fetal calf serum. In order to prepare a 
cytosolic cell extract, the cells were harvested, pelleted, and resus- 
pended on ice in 1 ml MES buffer (17 mM MES, pH 7.4, 2.5 mM 
EDTA, 250 mM sucrose, and 1 mM PMSF) per 1 × 10 r cells. The cells 
were lysed on ice in a glass homogeniser with 60 strokes, and after 
centrifugation at 150000×g for 1 h at 4°C, the amount of protein was 
determined with bovine serum albumin as standard [26]. The cytosolic 
extract was stored at -80°C. 
2.4. Competitive two solid phase biopanning-protein mixture 
A protein mixture (MIX) was made, containing equal amounts 
(w/v) of the following proteins: a-lactalbumin, [3-1actoglobulin, soy- 
bean trypsin inhibitor, bovine catalase, bovine serum albumin, and 
creatine kinase. This mixture was split into two aliquots and lactate 
dehydrogenase (LDH) was added to one of these (MIX+LDH). All 
coatings were with 5 ~tg/ml of each protein in 50 mM NaHCO3, pH 
9.6 overnight at 4°C. Blocking was with 4% skimmed milk powder in 
PBS (4% MPBS) at 30°C for 1 h. 
A schematic presentation f the panning system is shown in Fig. 1. 
An aliquot of 1012 colony-forming units (cfu) from the naive library, 
and competitive soluble MIX proteins (5 I.tg/ml of each protein) in 4 
ml 2% MPBS, were added to an immunotube (~ 1885 mm ~) (Nunc, 
Maxisorp) coated with competitive MIX proteins. After pre-incuba- 
tion for 20 rain at room temperature, an immunobead (,--28 mm 2) 
(custom made by Nunc, Maxisorp) coated with the target MIX+LDH 
proteins was added and the incubation continued for 2 h at room 
temperature. The immunobead was washed 20 times in PBS with 
0.2% Tween-20, and 20 times in PBS. The bound phage were eluted 
with 1 ml 100 ~M triethylamine for 10 min at room temperature and 
neutralised with 0.5 ml 1 M Tris, pH 7.4. Exponentially growing TG-1 
bacteria were infected with 1 ml of the eluate for 30 min at 37°C, and 
phage were produced by super-infection with the helper phage VCS- 
M13 (Stratagene) and growing the bacteria with shaking overnight at 
30°C. 
2.5. Competitive two solid phase biopanning-cytosolic cell extract from 
a melanoma cell line 
In all the experiments he same preparation of cytosolic proteins 
from FM55p was used. All the coatings were with 25 ~tg/ml of FM55p 
proteins in 50 mM NaHCO3, pH 9.6 overnight at 4°C. Blocking was 
with 4% MPBS at room temperature for 2 h. The naive library (10 ~2 
cfu) and competitive soluble FM55p proteins (25 ~tg/ml) were added 
in 4 ml 2% MPBS to an immunotube coated with competitive FM55p 
proteins. After preincubation for 20 min at room temperature, five 
immunobeads coated with FM55p proteins were added (see Fig. 1) 
and the incubation continued for 2 h at room temperature. The im- 
munobeads were then washed by soaking 5 times for 2 min in PBS 
with 0.1% Tween-20, once for 10 min in PBS with 0.1% Tween-20, 
and 3 times for 2 min in PBS, and the bound phage were eluted and 
propagated as described above. A selection, without competition, was 
performed simultaneously against FM55p proteins coated on five im- 
munobeads using the same washing conditions. 
2.6. Soluble expression of scFv 
Monoclonal scFv fragments were obtained from the periplasmatic 
fractions from 20 ml cultures of infected E. coli nonsuppressor strain 
HB2151 induced with 1 mM IPTG, and grown for 30 h at room 
temperature with shaking. Pellets of the bacterial cultures were resus- 
pended in 300 ~1 MOPS buffer (20 mM MOPS pH 7.5, 0.5 mM 
EDTA, 20% sucrose) and left on ice for 15 min. Subsequently, 1.6 
ml water was added to disrupt the outer bacterial membrane. The 
suspensions were centrifuged at 3000×g for 20 min at 4°C, and the 
supernatants were used as reagents in immunoblotting. 
2. 7. 9ElO anti-c-myc antibody 
The 9E10 anti-c-myc tag mouse monoclonal antibody was obtained 
from a hybridoma cell line provided by the European Collection of 
Animal Cell Cultures (ECACC). The cells were grown in RPMI 1640 
medium (Dulbecco, Life Technologies) upplemented with 5% Myo- 
clone (Life Technologies). The antibody was purified on a protein G- 
column, and stored in small aliquots (1 mg/ml) at -80°C until used. 
2.8. Test-panning assay 
The binding of the isolated polyclonal phage pools was determined 
by the number of cfu rescued after panning against proteins (25 p.g/ 
ml) coated overnight on immunotubes at4°C in 50 mM NaHCO3, pH 
9.6. Bacterial culture supernatants containing equal amounts of phage 
were added in 4 ml 2% MPBS and binding was allowed for 1 h at 
room temperature. The immunotubes were washed 10 times in PBS 
with 0.2% Tween-20, soaked 3 times for 5 min in PBS with 0.4% 
Tween-20, and were finally washed 10 times in PBS. The bound phage 
were eluted as described and an aliquot was used to infect TG-1 
bacteria. The number of cfu were determined by plating a serial dilu- 
tion of the infected bacteria onto agar plates containing ampicillin 
(100 ~tg/ml) and glucose (1% w/v), and incubating the plates overnight 
at 30°C. 
2.9. Phage ELISA 
Proteins were coated on microtitre plates (Greiner GmbH, Micro- 
lon) overnight at 4°C in 100 ~tl 50 mM NaHCO3, pH 9.6 per well. The 
plates were blocked with 270/.tl 4% MPBS per well at 30°C for 1 h. 
First, 50 H1 of bacterial culture supernatants, containing either poly- 
clonal phage or monoclonal phage produced from single ampicillin- 
resistant clones of infected TG-1 bacteria [8], were added together 
with 50 ~tl 4% MPBS. After 1 h incubation at room temperature 
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Fig. 1. Schematic presentation of the selection strategy. (A) In the 
competitive two solid phase system, the target proteins, MIX+LDH 
proteins or FM55p proteins, were coated on immunobead(s). The 
second solid phase support was an immunotube coated with compe- 
titive MIX proteins or competitive FM55p proteins, respectively. 
Moreover, the competitive proteins were added in solution. (B) In 
the control system, selections were performed on immunobeads in
an immunotube previously blocked overnight in 4% MPBS. 
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Fig. 2. Phage (101° cfu) in 100 I, tl 2% MPBS were added to wells in 
microtitre plates coated with antigen. (A) The reactivity of polyclo- 
nal phage from the third round was determined from wells coated 
with either MIX+LDH (2 ~tg/well) or MIX (2 ~g/well). Negative 
controls were performed by addition of phage to wells coated with 
4% MPBS (control 1), or by addition of phage from the naive unse- 
lected library to wells coated with either MIX (control 2) or 
MIX+LDH (control 3). (B) The reactivities of polyclonal phage 
from selections with or without competition were compared for re- 
activity against FM55p proteins (2 ~tg/well). 
the plates were washed 3 times in PBS with 0.05% Tween and 3 times 
in PBS, and horseradish peroxidase-conjugated anti-M13 antibody 
(Pharmacia Biotech) was added in a dilution of 1:1500 in 100 ~1 
2% MPBS for 1 h. After a final wash, the plates were developed 
with ortho-phenylenediamine (OPD) tablets (Kem-En-Tec), according 
to the manufacturer's in tructions, and the A490nm read. The specificity 
of the binding was assessed by ELISA assays using wells coated with 
the appropriate protein in dilution, and wells coated with irrelevant 
proteins. 
2.10. Immunoblotting 
The proteins were separated by SDS-polyacrylamide g l electro- 
phoresis and transferred to nitrocellulose filters (Amersham, Hy- 
bond-C Super) by semidry electroblotting. The blots were blocked 
in 4% MPBS overnight at 4°C. 
In phage-immunoblotting, bacterial culture supernatants containing 
phage were added in 2% MPBS and binding was allowed for 40 min 
at room temperature. The blots were washed 5 times for 5 min in PBS 
containing 0.4% Tween-20. Horseradish peroxidase-conjugated anti- 
M 13 antibody (Pharmacia Biotech) was added in a dilution of 1:1500 
in 2% MPBS. After 1 h incubation the blots were washed as described, 
and developed using a chemiluminescent detection system (Pierce, 
SuperSignal), according to the instructions of the manufacturer. 
In scFv immunoblotting, soluble scFv from the periplasm of in- 
fected HB2151 bacteria were added in 2% MPBS and binding was 
allowed for 1 h at room temperature. The blots were washed 5 times 
for 3 min in PBS containing 0.1% Tween-20, and 1 : 1000 of the anti-c- 
myc antibody (9El0) was added in 2% MPBS. After 1 h incubation, 
the blots were washed again, and 1:1500 horseradish peroxidase-con- 
jugated anti-mouse antibody (DAKO) was added for 1 h. Following a 
Table 1 
The number of colony forming units by test panning 
Input phage MIX coat MIX+LDH coat 
10 la MIX phage ~ 8 x 10 ~ cfu 2X l0 s cfu 
1011 unselected phage 3 x 105 cfu 2 x l0 s cfu 
aPolyclonal phage from the third round. See Section 2 for details. 
final wash, the blots were developed by chemiluminescent de ection as 
in phage-immunoblotting. 
3. Resu l ts  and d iscuss ion 
We used a naive library of approximately 108 scFv antibody 
fragments displayed on phage to investigate the possibility of 
selecting preferentially against a particular protein differen- 
tially occurring in two pools of proteins. The goal is to estab- 
lish a competitive panning procedure, which can be used to 
obtain phage antibodies against antigens expressed ifferen- 
tially in different cell populations. As this requires selection 
against various antigens simultaneously, we chose to work 
with a naive library, which is known to be robust and easy 
to use, and has been used to select antibodies towards several 
antigens [11]. The affinity of antibodies identified from this 
library is normally in the micromolar ange, but can be im- 
proved by affinity maturation [27-31]. 
The binding of proteins to plastic surfaces is known to alter 
the structural conformation of some proteins, thereby chang- 
ing the epitopes that are expressed [32]. In order to take this 
into account, a two solid phase system was developed, in 
which the competitive antigens were coated in the same man- 
ner as the protein of interest. Competitive proteins were, how- 
ever, also added in solution as described by others [13,24]. We 
chose to conduct competition along with the selections, rather 
than adsorbing against the competing extract after selections 
[23], as it was found hard to eliminate binders once enrich- 
ment to high numbers had occurred (unpublished observa- 
tions). 
By selecting against a protein mixture containing six pro- 
teins plus lactate dehydrogenase (MIX+LDH),  in the presence 
of the same six proteins (MIX) in competition, we were able 
to enrich preferentially for phage that were reactive against 
LDH. After three rounds of selection, the binding of the iso- 
lated polyclonal phage pools was tested by performing test- 
panning assays against MIX proteins and MIX+LDH pro- 
teins, respectively. The number of cfu calculated from the 
test panning against MIX proteins was comparable with 
that from the naive unselected library, suggesting non-signifi- 
cant binding against MIX proteins. In contrast, the test pan- 
Table 2 
Reactivity of monoclonal phage clones 
Clone obtained from Positives/total 
MIX phage, 1st 0/96 
MIX phage, 2nd 81196 (84%) 
MIX phage, 3rd 95196 (99%) 
FM55p phage, 5th, competitive 0/88 
FM55p phage, 5th, non-competitive 59/88 (67%) 
Individual clones were picked from colonies of infected TG-1 bacteria 
and 50 [xl of bacterial supernatants was tested in ELISA coated with 
LDH (1 txg/well) for MIX phage and FM55p proteins (2 ~tg/well) for 
FM55p phage. 
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Fig. 3. (A) Phage (101° cfu) in 100 txl 2% MPBS were added to 
wells coated with LDH in dilution, in order to test the specificity of 
the polyclonal phage (poly 1st and poly 3rd), and two clones ran- 
domly picked from the third round (clones E3 and H3). (B) Poly- 
clonal phage (3× 109 cfu) were pre-incubated for 20 min at room 
temperature with 0-4 i.tg of FM55p proteins in 100 },tl 2% MPBS, 
before addition to wells coated with FM55p protein (1 ~tg/well). 
ning against MIX+LDH proteins gave a 2.5 x 102 times high- 
er cfu (Table 1), suggesting a specific binding of the phage 
antibodies towards LDH. Concordant results were obtained 
by comparing ELISA signals from wells coated with MIX 
proteins with signals from wells coated with MIX+LDH pro- 
teins (Fig. 2A). Hence, the signals against MIX+LDH pro- 
teins were 10-fold higher than the background signals from 
negative controls, whereas the signals against MIX proteins 
alone were equal to the background signals. 
To analyse the relative number of positive clones reactive 
against LDH, 96 clones from each of the three rounds were 
analysed in ELISA assays. Clones with 2-fold higher signals 
than the average from unselected phage were considered pos- 
itive. Already after two rounds of competitive selection 
> 80% of the picked clones were positive against LDH (Table 
2). However, the mean signal (A490nm) obtained from positive 
clones of this round (0.623) was lower than that from the 
third round (1.444), indicating that the reactivity of the indi- 
vidual clones increased from the second to the third round, 
and that binders with higher affinity had been selected. The 
specificity of polyclonal and monoclonal phage was verified by 
ELISA coated with LDH in a dilution series (Fig. 3A), and by 
immunoblotting (Fig. 4). Likewise, the specificity of the solu- 
ble scFv antibody fragments was verified by immunoblotting 
(Fig. 4). In order to ensure that binders could be identified, 
not only against LDH, but also against he other proteins in 
the protein mixture, the library was panned against each of 
the proteins individually, and clones recognising all six were 
isolated (data not shown). 
The power of selection inhibition during the competitive 
panning was analysed by performing selections against an 
extract from a melanoma cell line (FM55p) with or without 
the same extract in competition. After the pannings, the bind- 
ing of the polyclonal phage pools against FM55p proteins was 
compared in ELISA (Fig. 2B). The reactivity of the polyclonal 
phage in ELISA (A490nm) towards FM55p proteins was 0.419 
after four rounds, and 0.757 after five rounds of selection 
without competition. In contrast, the competitive selections 
resulted in signals that were equal to the background signals 
(0.107). Also, individual clones from the fifth round were 
picked and tested against FM55p proteins in ELISA, in order 
to evaluate further the value of selection inhibition. Following 
competitive selection, none of the clones picked were positive 
(2-fold above background), whereas in comparison, 67% of 
the clones picked after selection without competition were 
positive (Table 2). The specificity of the phage, which had 
been selected without competition, was verified by inhibition 
ELISA showing reduction of the signals following addition of 
increasing amounts of FM55p proteins to the wells (Fig. 3B). 
Thus, the competitive procedure impeded the reactivity to- 
wards FM55p proteins. 
When aiming at subtraction between two components, the 
ideal situation is to have selection against all differences i- 
multaneously with selection inhibition of all similarities. The 
dilemma remains, however, that attempts to improve the effi- 
cacy of selection inhibition by using higher stringency during 
the panning rounds will tend to decrease the diversity in the 
subtracted phage pool, because low-affinity binders are lost 
[33]. Consequently, a less stringent approach may be more 
suitable in some cases. Also, the possibility of isolating phage 
antibodies against most of the differences may be increased by 
sub-fractionation f the cell extracts before panning in order 
to increase the density of the individual antigen coated, or by 
using different coating conditions in parallel to cover as many 
proteins as possible. 
A). Phage antibodies 
c 
LDH--* 
f • 
1 
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Fig. 4. In order to test the specificity against LDH, MIX proteins 
(a-f, 1 Ixg of each per lane) and LDH (1 ~tg per lane) were electro- 
phoresed and electroblotted to nitrocellulose filters. Each lane was 
cut out and probed individually with phage from bacterial superna- 
tants, or scFv antibody fragments obtained from periplasmatic puri- 
fications. (A) Immunoblots probed with polyclonal phage (2x 101° 
cfu per ml 2% MPBS) from the first round (lane 1) and third round 
(lane 2), or with phage (5X10 ° cfu per ml 2% MPBS) from the 
clones B5-2 (lane 3) and C5-1 (lane 4). (B) Immunoblots probed 
with polyclonal scFv fragments (1:3 in 2% MPBS) from the first 
round (lane 5) and third round (lane 6), or scFv fragments (1:10 in 
2% MPBS) from clones B5-2 (lane 7) and D10-2 (lane 8). 
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Very recently, a robust phagemid library, with a diversity of 
1.4 × 1010 scFv expressed on phage, has been developed [14]. 
In theory, such a library represents a source from which scFv 
antibody fragments with nanomolar affÉnities can be isolated 
against apparently any antigen. The chance of isolating cell 
population-specific antigens by competitive biopanning as de- 
scribed in this paper will increase once such libraries are avail- 
able, because high affinity allows more stringent panning and 
washing procedures, and because cross-reactivity should be 
minimal. High-affinity libraries will also improve the probabil- 
ity of identifying binders against low-expressed antigens, as 
the high affinity compensates for a low antigen density. 
Hence, the use of a large naive antibody library and the sub- 
tractive panning strategy described is likely to be a fast and 
easy way to identify research reagents directed against bio- 
markers of cellular extracts or biological fluids. Such antibod- 
ies would be useful in mapping differences in gene expression 
between two populations of cells, like between old and young 
cells or between transformed and non-transformed cells, and 
thus in an understanding of their phenotypes. 
Acknowledgements: We would like to thank Dr Greg Winter for 
kindly providing the antibody library. Dr Jesper Zeuthen for kindly 
providing the melanoma cell line, and Villy Jensen for providing the 
immunobeads. We are grateful to Dr Andrew Griffith for advice. This 
work was financially supported by The Danish Natural Science Re- 
search Council, The Institute of Experimental Clinical Research at the 
University of Aarhus, and Aage Bangs Foundation. 
References 
[1] Smith, G.P. (1985) Science 228, 1315-1317. 
[2] Clackson T. and Wells, J.A. (1994) Trends Biotechnol. 12, 173- 
184. 
[3] Winter, G. and Milstein, C. (1991) Nature 349, 293-299. 
[4] Lerner, R,A., Kang, A.S., Bain, J.D., Burton, D.R. and Barbas, 
C.F. (1991) Science 258, 1313 1314. 
[5] Winter, G., Griffiths, A.D., Hawkins, R.E. and Hoogenboom, 
H.R. (1994) Annu. Rev. Immunol. 12, 433-455. 
[6] Burton, D.R., Barbas, C.F., Persson, M.A.A., Koenig, S., Cha- 
nock, R.M. and Lerner, R.A. (1991) Proc. Natl. Acad. Sci. USA 
88, 10134--10137. 
[7] Clackson, T., Hoogenboom, H.R., Griffiths, A.D. and Winter, 
G. (1991) Nature 352, 621 628. 
[8] Marks, J.D., Hoogenboom, H.R., Bonnert, T.P., McCafferty, J., 
Griffiths, A.D. and Winter, G. (1991) J. Mol. Biol. 222, 581-597. 
[9] Hoogenboom, H.R. and Winter, G. (1992) J. Mol. Biol. 227, 
381-388. 
[10] Griffiths, A.D., Malmqvist, M., Marks, J.D., Bye, J.M., Emble- 
ton, M.J., McCafferty, J., Baier, M., Holliger, K.P., Gorick, 
B.D., Hughes-Jones, N.C., Hoogenboom, H.R. and Winter, G. 
(1993) EMBO J. 12, 725-734. 
75 
[11] Nissim, A., Hoogenboom, H.R., Tomlinson, I.M., Flynn, G., 
Midgley, C., Lane, D. and Winter, G. (1994) EMBO J. 13, 
692~98. 
[12] Griffiths, A.D., Williams, S.C., Hartley, O., Tomlinson, I.M., 
Waterhouse, P., Crosby, W.L., Kontermann, R.E., Jones, P.T., 
Low, N.M., Allison, T.J., Prospero, D. Hoogenboom, H.R., Nis- 
sim, A., Cox, J.P.L., Harrison, J.L., Zaaccolo, M., Gherardi, E. 
and Winter, G. (1994) EMBO J. 13, 3245-3260. 
[13] de Kruif, J., Boel, E. and Logtenberg, T. (1995) J. Mol. Biol. 248, 
97-105. 
[14] Vaughan, T.J., Williams, A.J., Pritchard, K., Osbourn, J.K., 
Pope, A.R., Earnshaw, J.C., McCafferty, J., Hodits, R.A., Wil- 
ton, J. and Johnson, K.S. (1996) Nature Biotechnol. 14, 309-314. 
[15] Huston, J.S., McCartney, J., Tai, M., Mottola-Hartshorn, C., 
Jin, D., Warren, F., Keck, P. and Oppermann, H. (1992) Int. 
Rev. Immunol. 10, 195~17. 
[16] Chester, K.A., Begent, R.H.J., Robson, L., Keep, P., Pedley, 
R.B., Boden, J.A., Boxer, G., Green, A., Winter, G., Cochet, 
O. and Hawkins, R.E. (1994) Lancet 343, 455-456. 
[17] Schier, R., Marks, J.D., Wolf, E.J., Apell, G., Wong, C., 
McCartney, J.E., Bookman, M.A., Huston, J.S., Houston, 
L.L., Weiner, L.M. and Adams, G.P. (1995) Immunotechnology 
1, 73-81. 
[18] Marks, J.D., Ouwehand, W.H., Bye, J.M., Finnern, R., Gorick, 
B.D., Voak, D., Thorpe, S.J., Hughes-Jones, N.C. and Winter, 
G. (1993) Bio/Technology 11, 1145 1149. 
[19] Barry, M.A., Dower, W.J. and Johnston, S.A. (1996) Nature 
Med. 2, 299-305. 
[20] de Kruif, J., Terstappen, L., Boel, E. and Logtenberg, T. (1995) 
Proc. Natl. Acad. Sci. USA 92, 3938 3942. 
[21] Meulemans, E.V., Slobbe, R., Wasterval, P., Ramaekers, F.C.S. 
and van Eys, G.J.J.M. (1994) J. Mol. Biol. 244, 353-360. 
[22] Sanna, P.P., Williamson, R.A., De Logu, A., Bloom, F.E. and 
Burton, D.R. (1995) Proc. Natl. Acad. Sci. USA 92, 6439-6443. 
[23] Cai, X. and Garen, A. (1995) Proc. Natl. Acad. Sci. USA 92, 
6537-6541. 
[24] Ames, R.S., Tornetta, M.A., Jones, C.S. and Tsui, P. (1994) J. 
Immunol. 152, 4572-4581. 
[25] Kirkin, A.F., Petersen, T.R., Olsen, A.C., Li, L., Thor Straten, P. 
and Zeuthen, J. (1995) Cancer Immunol. Immunother. 41, 71-81. 
[26] Bradford, M.M. (1976) Anal. Biochem. 72, 248-254. 
[27] Marks, J.D., Griffiths, A.D., Malmqvist, M., Clackson, T.P., 
Bye, J.M. and Winter, G. (1992) Biofrechnology 10, 779-783. 
[28] Gram, H., Marconi, L., Barbas, C.F., Collet, T.A., Lerner, R.A. 
and Kang, A.S. (1992) Proc. Natl. Acad. Sci. USA 89, 3576- 
3580. 
[29] Yang, W., Green, K., Pinz-Sweeney, S., Briones, A.T., Burton, 
D.R. and Barbas, C.F. (1995) J. Mol. Biol. 254, 392-403. 
[30] Schier, R., Bye, J., Apell, G., McCall, A., Adams, G.P., Malm- 
qvist, M., Weiner, L.M. and Marks, J.D. (1996) J. Mol. Biol. 
255, 28-43. 
[31] Thompson, J., Pope, T., Tung, J., Chan, C., Hollis, G., Mark, G. 
and Johnson, K.S. (1996) J. Mol. Biol. 256, 77-88. 
[32] Schwab, C. and Bosshard, H.R. (1992) J. Immunol. Methods 
•47, 125-134. 
[33] Hawkins, R.E., Russell, S.J. and Winter, G. (1992) J. Mol. Biol. 
226, 889-896. 
